Evaluation of the relation between patient characteristics and the state of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer receiving paclitaxel and carboplatin

By Furukawa Naoto   Akasaka Juria   Shigemitsu Aiko   Sasaki Yoshikazu   Nagai Akira   Kawaguchi Ryuji   Kobayashi Hiroshi  

Archives of Gynecology and Obstetrics, Vol. 289, Iss. 4, 2014-04 ,pp. : 859-864

Springer Publishing Company

Access to resources Recommend Favorite

Is platinum-based chemotherapy with paclitaxel effective in optimally debulked patients with advanced ovarian cancer?

By Roovers J.-P.W.R.   Sijmons E.A.   van Leeuwen J.H.S.   Mol B.W.J.   Witteveen P.O.   Slee P.H.T.J.   Heintz A.P.M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 97, Iss. 1, 2001-07 ,pp. : 80-84

Elsevier

Access to resources Recommend Favorite

Hypersensitivity reactions in paclitaxel treatment of ovarian cancer patients

By Lehoczky O.   Bagaméri Andrea   Udvary J.   Pulay T.  

Journal of Obstetrics & Gynaecology, Vol. 22, Iss. 3, 2002-05 ,pp. : 312-313

Informa Healthcare

Access to resources Recommend Favorite

A rare case of ovarian carcinosarcoma successfully treated with the neoadjuvant chemotherapy of paclitaxel and ifosfamide

By Okazawa M.   Masuhara K.   Miyoshi A.   Fujiwara K.   Ohta Y.   Yoshino K.   Kamiura S.   Tomita Y.  

Journal of Obstetrics & Gynaecology, Vol. 31, Iss. 3, 2011-04 ,pp. : 274-275

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant chemotherapy in the management of advanced epithelial ovarian cancer

By Hou June Y   Schwartz Peter E  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 3, 2007-05 ,pp. : 321-329

Informa Healthcare

Access to resources Recommend Favorite